1998
DOI: 10.1001/archderm.134.10.1216
|View full text |Cite
|
Sign up to set email alerts
|

Nail Changes in Patients Infected With Human Immunodeficiency Virus

Bernard Cribier,
Marcello Leiva Mena,
David Rey
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

10
49
0
2

Year Published

1999
1999
2017
2017

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 108 publications
(61 citation statements)
references
References 29 publications
10
49
0
2
Order By: Relevance
“…(9) The prevalence of pruritic papular eruptions in our study was 8.3%, whereas other studies report a prevalence ranging from 7.7% to 35.8%. (9)(10)(11) We observed longitudinal melanonychia in 16.7% of the patients similar to that reported by Cribier et al (11) whereas Kore et al reported nail discoloration in 5.4% of their study population. (12) We also noted that when there was a decrease in the CD4 counts, the patient tended to be in a higher HIV clinical staging, consistent with other studies.…”
Section: Malesupporting
confidence: 88%
“…(9) The prevalence of pruritic papular eruptions in our study was 8.3%, whereas other studies report a prevalence ranging from 7.7% to 35.8%. (9)(10)(11) We observed longitudinal melanonychia in 16.7% of the patients similar to that reported by Cribier et al (11) whereas Kore et al reported nail discoloration in 5.4% of their study population. (12) We also noted that when there was a decrease in the CD4 counts, the patient tended to be in a higher HIV clinical staging, consistent with other studies.…”
Section: Malesupporting
confidence: 88%
“…Cribier B et all showed In their study; 35.6% of the population had or gave a history of nail changes. 5 In our observation, 67% of our attendees were males while 33% were females. This pattern was seen throughout the age ranges.…”
Section: Age Range Number Of Patients No Of Males No Of Femalesmentioning
confidence: 49%
“…In a report of patients from Canada and Brazil, WSO had prevalence of 3.3% and 5% and for PWSO of 1.5% and 3% respectively. The overall prevalence for onychomycosis in HIV infected patients was reported of 23.2% Cribier et al, 1998;Dompmartin et al, 1990;Gupta et al 2000;Noppakun & Head, 1986;Weismann et al 1988). Among patients living with HIV/AIDS, onychomycosis is the fourth most common dermatological manifestation, with an incidence of 10-44%, and an estimated prevalence 15-40%.…”
Section: Epidemiologymentioning
confidence: 99%